3D inkjet printing of tablets exploiting bespoke complex geometries for controlled and tuneable drug release
- Submitting institution
-
The University of Leeds
- Unit of assessment
- 12 - Engineering
- Output identifier
- MECH-94
- Type
- D - Journal article
- DOI
-
10.1016/j.jconrel.2017.06.025
- Title of journal
- Journal of Controlled Release
- Article number
- -
- First page
- 207
- Volume
- 261
- Issue
- -
- ISSN
- 0168-3659
- Open access status
- Compliant
- Month of publication
- June
- Year of publication
- 2017
- URL
-
-
- Supplementary information
-
https://ars.els-cdn.com/content/image/1-s2.0-S0168365917306892-mmc1.docx
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
7
- Research group(s)
-
-
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- This publication introduces a new method to control drug release in the body using 3D printing by manipulating the surface area to volume ratio of tablets using unprecedented complex tablet designs. It uses cost-effective and highly scalable inkjet printing technology, which has considerable promise to make the production of personalised medicine a reality. This approach has attracted further collaboration with AstraZeneca (email on request) and underpinned a £5.5M Prosperity Partnership award (EP/S035990/1).
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
